Yoga practice and frequency improved self-reported cognitive problems among breast cancer survivors
the ONA take:
Cancer survivors often report cognitive problems. In addition, physical activity decreases over the course of cancer treatment. Cognitive function is improved with physical activity in noncancer populations; however, evidence of a link between physical activity and cognition among patients with cancer is limited.
A recent randomized, controlled trial investigated the impact of a yoga intervention on fatigue and inflammation among breast cancer survivors. In the parent trial, 200 posttreatment survivors of breast cancer stage 0-IIIa were randomized to a 12-week Hatha yoga intervention or a wait list control group. Those in the intervention group attended twice-weekly yoga sessions.
Cognitive complaints were self-reported via the Breast Cancer Prevention Trial Cognitive Problems Scale at baseline, immediately postintervention, and at 3-month follow-up. In this secondary analysis, no significant difference was seen between the groups immediately postintervention. However, the yoga participants’ scores on the self-report Scale were an average of 3% lower than those of the wait list participants at the 3-month follow-up.
Furthermore, those who practiced yoga more frequently reported significantly fewer cognitive problems that those who practiced less frequently. The researchers conclude that yoga can effectively reduce cognitive complaints among survivors of breast cancer.
Recent trial investigated impact of yoga intervention on fatigue and inflammation in breast cancer survivors.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Aggressive Therapy Provides No Additional Advantage in Metastatic Prostate Cancer
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- FDA, ASHP Actions to Prevent or Manage Chemotherapy Drug Shortages
- Breast Cancer Screening Recommendations Not Completely Reflective of Race, Age
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Approach and Management of Checkpoint Inhibitor-related Immune Hepatitis
- Revised AJCC8 Demonstrates Superior Tumor Classification for HNCSCC
- Oral Androgen Receptor Inhibitor Granted FDA Approval for Nonmetastatic CRPC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|